Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Sangsang Qiu, Ye Shen, Hongqiu Pan, Jianming Wang & Qun Zhang. (2015) Effectiveness and safety of oseltamivir for treating influenza: an updated meta-analysis of clinical trials. Infectious Diseases 47:11, pages 808-819.
Read now
Read now
Paolo Preziosi. (2011) Influenza pharmacotherapy: present situation, strategies and hopes. Expert Opinion on Pharmacotherapy 12:10, pages 1523-1549.
Read now
Read now
James M. Williams. (2009) 2009 update in prevention, evaluation, and outpatient treatment of influenza. Current Medical Research and Opinion 25:4, pages 817-828.
Read now
Read now
John G Gums, Elise M Pelletier & William A Blumentals. (2008) Oseltamivir and influenza-related complications, hospitalization and healthcare expenditure in healthy adults and children. Expert Opinion on Pharmacotherapy 9:2, pages 151-161.
Read now
Read now
Maarten J Postma, Paul Beardsworth & Jan C Wilschut. (2008) Cost effectiveness of oseltamivir treatment of influenza: a critique of published methods and outcomes. Journal of Medical Economics 11:4, pages 743-768.
Read now
Read now
Richard J Whitley. (2007) The role of oseltamivir in the treatment and prevention of influenza in children. Expert Opinion on Drug Metabolism & Toxicology 3:5, pages 755-767.
Read now
Read now
Articles from other publishers (32)
Robyn Harrison, Samira Mubareka, Jesse Papenburg, Tilman Schober, Upton D Allen, Todd F Hatchette & Gerald A Evans. (2023) AMMI Canada 2023 update on influenza: Management and emerging issues. Journal of the Association of Medical Microbiology and Infectious Disease Canada, pages 176-186.
Crossref
Crossref
Phyo T Htoo, Gregory Measer, Robert Orr, Justin Bohn, Alfred Sorbello, Henry Francis, Sarah K Dutcher, Austin Cosgrove, Amanda Carruth, Sengwee Toh & Noelle M Cocoros. (2022) Evaluating Confounding Control in Estimations of Influenza Antiviral Effectiveness in Electronic Health Plan Data. American Journal of Epidemiology 191:5, pages 908-920.
Crossref
Crossref
Kyeong Hyang Byeon, Jaiyong Kim, Bo Youl Choi, Jin Yong Kim & Nakyoung Lee. (2020) Factors Affecting the Incidence of Hospitalized Pneumonia after Influenza Infection in Korea Using the National Health Insurance Research Database, 2014–2018: Focusing on the Effect of Antiviral Therapy in the 2017 Flu Season. Journal of Korean Medical Science 35:38.
Crossref
Crossref
Fred Y Aoki, Upton D Allen, Samira Mubareka, Jesse Papenburg, H Grant Stiver & Gerald A Evans. (2019) Use of antiviral drugs for seasonal influenza: Foundation document for practitioners—Update 2019. Official Journal of the Association of Medical Microbiology and Infectious Disease Canada 4:2, pages 60-82.
Crossref
Crossref
Brian R. Lee, Ferdaus Hassan, Mary Anne Jackson & Rangaraj Selvarangan. (2019) Impact of multiplex molecular assay turn-around-time on antibiotic utilization and clinical management of hospitalized children with acute respiratory tract infections. Journal of Clinical Virology 110, pages 11-16.
Crossref
Crossref
Suchitra Rao, Ann-Christine Nyquist & Paul C. Stillwell. 2019. Kendig's Disorders of the Respiratory Tract in Children. Kendig's Disorders of the Respiratory Tract in Children
460
465.e2
.
Patrick D. Evers, Michelle Starr, Michael J. McNeil, Laura O'Neill, Andrea Posa, Timothy Savage & Russell Migita. (2017) Suspected Pediatric Influenza Risk-Stratification Algorithm. Pediatric Emergency Care Publish Ahead of Print.
Crossref
Crossref
Mercedes Bueno, Cristina Calvo, Ana Méndez-Echevarría, María Isabel de José, Mar Santos, Jaime Carrasco, Miriann Tovizi, Sara Guillén, Ana de Blas, Marta Llorente, Alfredo Tarrago, Luis Escosa, María José Cilleruelo, Cristina Tomatis, Daniel Blazquez, Enrique Otheo, Diana Mazagatos & Maria Luz García-García. (2013) Oseltamivir Treatment for Influenza in Hospitalized Children Without Underlying Diseases. Pediatric Infectious Disease Journal 32:10, pages 1066-1069.
Crossref
Crossref
Francisco López-Medrano, Elisa Cordero, Joan Gavaldá, Josep M. Cruzado, M. Ángeles Marcos, Pilar Pérez-Romero, Nuria Sabé, Miguel Ángel Gómez-Bravo, Juan Francisco Delgado, Evelyn Cabral & Jordi Carratalá. (2013) Management of influenza infection in solid-organ transplant recipients: Consensus statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the Spanish Network for Research in Infectious Diseases (REIPI). Enfermedades Infecciosas y Microbiología Clínica 31:8, pages 526.e1-526.e20.
Crossref
Crossref
Upton D Allen. (2013) L’utilisation d’antiviraux contre l’influenza : des conseils pour les praticiens en 2012-2013 – Sommaire relatif à la pédiatrie. Paediatrics & Child Health 18:3, pages 159-162.
Crossref
Crossref
Charles R. Beck, Rachel Sokal, Nachiappan Arunachalam, Richard Puleston, Anna Cichowska, Anthony Kessel, Maria Zambon & Jonathan S. Nguyen-Van-Tam. (2013) Neuraminidase inhibitors for influenza: a review and public health perspective in the aftermath of the 2009 pandemic. Influenza and Other Respiratory Viruses 7, pages 14-24.
Crossref
Crossref
Masayuki Kobayashi, Satoko Ohfuji, Wakaba Fukushima, Shiro Sugiura, Urara Kohdera, Yuhei Itoh, Saburo Ide, Keizou Ohbu & Yoshio Hirota. (2012) Pediatric hospitalizations with influenza A infection during the 2009-2010 pandemic in five hospitals in Japan. Pediatrics International 54:5, pages 613-618.
Crossref
Crossref
Shikha Garg, Alicia M. Fry, Monica Patton, Anthony E. Fiore & Lyn Finelli. (2012) Antiviral Treatment of Influenza in Children. Pediatric Infectious Disease Journal 31:2, pages e43-e51.
Crossref
Crossref
James R. Smith, Craig R. Rayner, Barbara Donner, Martina Wollenhaupt, Klaus Klumpp & Regina Dutkowski. (2011) Oseltamivir in seasonal, pandemic, and avian influenza: a comprehensive review of 10-years clinical experience. Advances in Therapy 28:11, pages 927-959.
Crossref
Crossref
Karen M. Clements, Jeremy Chancellor, Kristin Nichol, Kelly DeLong & David Thompson. (2011) Cost-Effectiveness of a Recommendation of Universal Mass Vaccination for Seasonal Influenza in the United States. Value in Health 14:6, pages 800-811.
Crossref
Crossref
Erica Y. Chung & Vincent W. Chiang. (2011) Influenza Vaccination, Diagnosis, and Treatment in Children. Pediatric Emergency Care 27:8, pages 760-769.
Crossref
Crossref
Carol J. Fairchild, Emily Durden, Zhun Cao & Patrick Smale. (2011) Outcomes and Cost Comparison of Three Therapeutic Approaches to Allergic Rhinitis. American Journal of Rhinology & Allergy 25:4, pages 257-262.
Crossref
Crossref
Fatimah S. Dawood, Anthony Fiore, Laurie Kamimoto, Anna Bramley, Arthur Reingold, Ken Gershman, James Meek, James Hadler, Kathryn E. Arnold, Patricia Ryan, Ruth Lynfield, Craig Morin, Mark Mueller, Joan Baumbach, Shelley Zansky, Nancy M. Bennett, Ann Thomas, William Schaffner, David Kirschke & Lyn Finelli. (2010) Burden of Seasonal Influenza Hospitalization in Children, United States, 2003 to 2008. The Journal of Pediatrics 157:5, pages 808-814.
Crossref
Crossref
James R. Smith, Robert E. Ariano & Stephen Toovey. (2010) The use of antiviral agents for the management of severe influenza. Critical Care Medicine 38, pages e43-e51.
Crossref
Crossref
R. Dutkowski. (2010) Oseltamivir in seasonal influenza: cumulative experience in low- and high-risk patients. Journal of Antimicrobial Chemotherapy 65:Supplement 2, pages ii11-ii24.
Crossref
Crossref
Pritish K. Tosh, Robert M. Jacobson & Gregory A. Poland. (2010) Influenza Vaccines: From Surveillance Through Production to Protection. Mayo Clinic Proceedings 85:3, pages 257-273.
Crossref
Crossref
Garth Meckler & Susan Lindemulder. (2009) Fever and Neutropenia in Pediatric Patients with Cancer. Emergency Medicine Clinics of North America 27:3, pages 525-544.
Crossref
Crossref
Pedro A. Piedra, Kathy L. Schulman & William A. Blumentals. (2009) Effects of Oseltamivir on Influenza-Related Complications in Children With Chronic Medical Conditions. Pediatrics 124:1, pages 170-178.
Crossref
Crossref
B. R. Ruf & T. Szucs. (2009) Reducing the Burden of Influenza-Associated Complications with Antiviral Therapy. Infection 37:3, pages 186-196.
Crossref
Crossref
Lance C. Jennings, Heino Skopnik, Isabel Burckhardt, Irene Hribar, Luc Del Piero & Klaus A. Deichmann. (2009) Effect of rapid influenza testing on the clinical management of paediatric influenza. Influenza and Other Respiratory Viruses 3:3, pages 91-98.
Crossref
Crossref
Scott A. Harper, John S. Bradley, Janet A. Englund, Thomas M. File, Stefan Gravenstein, Frederick G. Hayden, Allison J. McGeer, Kathleen M. Neuzil, Andrew T. Pavia, Michael L. Tapper, Timothy M. Uyeki & Richard K. Zimmerman. (2009) Seasonal Influenza in Adults and Children—Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management: Clinical Practice Guidelines of the Infectious Diseases Society of America. Clinical Infectious Diseases 48:8, pages 1003-1032.
Crossref
Crossref
Jeffrey A. Linder, Harry Reyes Nieva & William A. Blumentals. (2009) Antiviral and Antibiotic Prescribing for Influenza in Primary Care. Journal of General Internal Medicine 24:4, pages 504-510.
Crossref
Crossref
S Ward Casscells, Elder Granger, Amii M Kress & Andrea Linton. (2009) The association between oseltamivir use and adverse neuropsychiatric outcomes among TRICARE beneficiaries, ages 1 through 21 years diagnosed with influenza. International Journal of Adolescent Medicine and Health 21:1.
Crossref
Crossref
Allison J. McGeer. (2009) Diagnostic Testing or Empirical Therapy for Patients Hospitalized with Suspected Influenza: What to Do?. Clinical Infectious Diseases 48:S1, pages S14-S19.
Crossref
Crossref
William Paul Glezen. (2008) Modifying Clinical Practices to Manage Influenza in Children Effectively. Pediatric Infectious Disease Journal 27:8, pages 738-743.
Crossref
Crossref
Richard J Whitley. (2007) The role of oseltamivir in the treatment and prevention of influenza in children. Expert Opinion on Drug Metabolism & Toxicology 3:5, pages 755-767.
Crossref
Crossref
Eric A. Orzeck, Nianwen Shi & William A. Blumentals. (2007) Oseltamivir and the risk of influenza-related complications and hospitalizations in patients with diabetes. Clinical Therapeutics 29:10, pages 2246-2255.
Crossref
Crossref